Physician profile
Lloyd Ratner
NPI 1437190089
$31,910.64
in general payments reported to CMS, 2019-2025
14 companies · $13K in 2025
The $13K reported for 2025 was more than what 93% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $204 · 2021: $125 · 2022: $12K · 2023: $2,410 · 2024: $3,767 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $1,609 · Debt Forgiveness: $1,500 · Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,191.50 |
| Travel and Lodging | $1,608.75 |
| Debt Forgiveness | $1,500.00 |
| Food and Beverage | $698.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $21,664.49 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $4,684.60 | 2023-2025 | Nulojix |
| Immucor, INC. | $2,975.00 | 2022 | |
| Intuitive Surgical, INC. | $1,783.89 | 2022-2023 | Davinci Xi |
| Veloxis Pharmaceuticals, INC. | $389.35 | 2019-2022 | |
| Csl Behring | $161.47 | 2020 | |
| Mallinckrodt Enterprises LLC | $71.99 | 2019 | |
| Kamada Ltd. | $47.39 | 2023-2025 | |
| Covidien Lp | $42.14 | 2020 | |
| Ethicon US, LLC | $40.91 | 2024 | |
| Scpharmaceuticals INC. | $35.85 | 2025 | |
| Conmed Corporation | $13.56 | 2024 | Airseal |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Ratner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.